Jubilant Pharmova Limited (BOM:530019)
923.75
+17.40 (1.92%)
At close: Sep 4, 2026
Jubilant Pharmova Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Jubilant Pharmova stock has a consensus rating of "Hold" and an average price target of ₹1,089. The average 1-year stock price forecast is 17.83% higher than the current stock price, while the lowest is ₹850.00 (-7.98%) and the highest is ₹1,327 (+43.65%).
Price Target: ₹1,089 (+17.83%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Jubilant Pharmova stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 1 | 1 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
93.80B
from 82.80B
Increased by 13.29%
Revenue Next Year
106.78B
from 93.80B
Increased by 13.84%
EPS This Year
28.10
from 27.49
Increased by 2.21%
EPS Next Year
50.55
from 28.10
Increased by 79.89%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.